Factors associated with levothyroxine withdrawal and development of a prediction model in primary hypothyroidism - Report - MDSpire

Identifying Factors Linked to Levothyroxine Discontinuation and Creating a Predictive Model for Primary Hypothyroidism

  • By

  • Wanli Zheng

  • Yibei Tang

  • Xuanyu Chen

  • Wang Ye

  • Jingyao Yu

  • Yihan Sun

  • Bin Zhang

  • Guangli Wu

  • Jipeng Zheng

  • Yuqing Wang

  • Jianchun Cui

  • Li Lu

  • Xingai Ju

  • July 21, 2026

Share

Clinical Report: Identifying Factors Linked to Levothyroxine Discontinuation

Overview

This study identifies factors associated with successful levothyroxine withdrawal in primary hypothyroidism and develops a predictive model. Key predictors include younger age and subclinical hypothyroidism, while TPOAb positivity and heterogeneous thyroid echotexture are linked to lower success rates.

Background

Primary hypothyroidism is a prevalent endocrine disorder requiring long-term levothyroxine (L-T4) therapy. This study aims to identify factors associated with successful L-T4 withdrawal.

Data Highlights

CharacteristicOdds Ratio (OR)95% Confidence Interval (CI)P-value
Younger Age0.9010.852–0.953< 0.001
Subclinical Hypothyroidism4.8791.343–17.7230.016
TPOAb Positivity0.1500.040–0.5560.005
Heterogeneous Echotexture0.1550.032–0.7510.021

Key Findings

  • 35.5% of patients achieved successful L-T4 withdrawal.
  • Younger age is significantly associated with higher withdrawal success.
  • Subclinical hypothyroidism increases the likelihood of successful withdrawal.
  • TPOAb positivity and heterogeneous thyroid echotexture decrease the likelihood of successful withdrawal.
  • The predictive model demonstrated excellent discrimination (AUC = 0.899).

Clinical Implications

Younger age and subclinical hypothyroidism are associated with higher likelihood of L-T4 withdrawal success, while TPOAb positivity and heterogeneous thyroid echotexture are associated with lower likelihood.

Conclusion

The study provides a predictive model for L-T4 withdrawal success.

Related Resources & Content

  1. Frontiers in Endocrinology, 2026 -- Analysis of Risk Factors for Hypothyroidism in Initially Euthyroid Patients with Positive Thyroid Autoantibodies
  2. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Impact of Prior Psychiatric Conditions on Liothyronine Administration in Hypothyroidism
  3. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Effects of Low-Dose Maintenance Therapy Prior to Stopping Antithyroid Medications on Relapse Rates in Graves’ Disease
  4. ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism - PMC
  5. Rationale and impact | Thyroid disease: assessment and management | Guidance | NICE
  6. The Journal of Clinical Endocrinology & Metabolism — Machine Learning Approaches for Optimizing Carbimazole Dosing in the Management of Hyperthyroidism
  7. Thyroxine overuse and clinical indices guiding successful treatment withdrawal.
  8. De-prescribing levothyroxine in primary care – results of a feasibility study.
  9. ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism - PMC
  10. Rationale and impact | Thyroid disease: assessment and management | Guidance | NICE
  11. Clinical Outcomes After Discontinuation of Thyroid Hormone Replacement: A Systematic Review and Meta-Analysis - PubMed

Original Source(s)

Related Content